{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:14:51Z","timestamp":1761128091077},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.clindermatol.2003.12.033","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T17:36:16Z","timestamp":1085852176000},"page":"29-33","source":"Crossref","is-referenced-by-count":15,"title":["The cosmetic use of botulinum toxin type B in the upper face"],"prefix":"10.1016","volume":"22","author":[{"given":"Neil S","family":"Sadick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.12.033_BIB1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archderm.125.8.1090","article-title":"The microanatomical basis of facial frown lines","volume":"125","author":"Pierard","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1076-0512(98)00190-3","article-title":"Understanding botulinum toxin","volume":"24","author":"Wider","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","article-title":"Response and immunoresistance to botulinum toxin injections","volume":"45","author":"Jankovic","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A\u2013responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A\u2013resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/sder.2001.24421","article-title":"Botulinum toxin type B","volume":"20","author":"Callaway","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhn.2002.124706","article-title":"Botulinum toxin type B (Myobloc) in the management of hyperkinetic facial lines","volume":"126","author":"Ramirez","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14764170260030117","article-title":"Botulinum toxins types A and B for brow furrows","volume":"4","author":"Lowe","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1524-4725.2002.02037.x","article-title":"Botulinum toxin type B (Myobloc) for glabellar wrinkles","volume":"28","author":"Sadick","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB11","doi-asserted-by":"crossref","unstructured":"Sadick NS. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 units for the treatment of glabellar wrinkles. Dermatol Surg 2003;29:501\u22127","DOI":"10.1046\/j.1524-4725.2003.29122.x"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB12","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00002508-200211001-00012","article-title":"A review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes","volume":"18","author":"Glogau","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clindermatol.2003.12.033_BIB13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14764170260030126","article-title":"Botulinum B treatment of the glabellar and frontalis regions","volume":"4","author":"Spencer","year":"2002","journal-title":"J Cosmet Laser Ther"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T09:09:44Z","timestamp":1585818584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0738081X03001482"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.12.033","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}